AstraZeneca (AZN) News Today → Stock-Picking AI Predicts #1 Stock of 2024 (From Altimetry) (Ad) Free AZN Stock Alerts $76.35 +0.55 (+0.73%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineM&T Bank Corp Sells 11,178 Shares of AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - May 5 at 10:34 AMAstraZeneca PLC (NASDAQ:AZN) Position Boosted by Raymond James Financial Services Advisors Inc.marketbeat.com - May 4 at 9:35 PMAstraZeneca PLC (AZN)finance.yahoo.com - May 4 at 12:10 PMNatixis Advisors L.P. Grows Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - May 3 at 9:52 PMWesbanco Bank Inc. Buys New Stake in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - May 3 at 12:09 AMCALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trialbusinesswire.com - May 2 at 7:00 AMHowe & Rusling Inc. Has $10.54 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - May 1 at 4:00 PMAstraZeneca Jumps Ahead of Showing New Databaystreet.ca - May 1 at 10:07 AMAstraZeneca Jumps Ahead of Showing New Databaystreet.ca - May 1 at 10:07 AMAstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - April 30 at 10:53 AMAtria Wealth Solutions Inc. Increases Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 30 at 6:25 AMAstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknownbenzinga.com - April 29 at 3:41 PMAstraZeneca’s Fasenra: Approval for asthma may initiate COPD approvalfinance.yahoo.com - April 29 at 3:03 PMUK Stocks: AstraZeneca (AZN) Shares Rise on Promising Breast Cancer Drug Updatesmarkets.businessinsider.com - April 29 at 3:03 PMAstraZeneca PLC (NASDAQ:AZN) Short Interest Updatemarketbeat.com - April 29 at 12:06 PMDouble Good News For AstraZeneca's Breast Cancer Drugsmsn.com - April 29 at 10:40 AMENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralowbusinesswire.com - April 29 at 7:00 AMLeerink Partnrs Equities Analysts Increase Earnings Estimates for AstraZeneca PLC (NASDAQ:AZN)americanbankingnews.com - April 29 at 4:22 AMENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trialbusinesswire.com - April 29 at 2:00 AMAstraZeneca PLC (NASDAQ:AZN) Stock Holdings Raised by Fiduciary Group LLCmarketbeat.com - April 28 at 8:15 PMJ&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decademsn.com - April 28 at 1:35 PMBMO Capital Markets Increases AstraZeneca (NASDAQ:AZN) Price Target to $82.00americanbankingnews.com - April 28 at 2:42 AMQ1 2024 EPS Estimates for AstraZeneca PLC Lowered by Analyst (NASDAQ:AZN)americanbankingnews.com - April 27 at 1:30 AMAstraZeneca (NASDAQ:AZN) Price Target Raised to $82.00marketbeat.com - April 26 at 2:44 PMPharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updatesfinance.yahoo.com - April 26 at 2:38 PMAstraZeneca: Strong In A Weak Marketseekingalpha.com - April 26 at 11:33 AMBrokers Set Expectations for AstraZeneca PLC's Q1 2024 Earnings (NASDAQ:AZN)marketbeat.com - April 26 at 7:52 AMAstraZeneca (NASDAQ:AZN) Shares Gap Up to $71.20marketbeat.com - April 25 at 4:49 PMAstraZeneca reinforcing supply chain amid global tensions: CEOfinance.yahoo.com - April 25 at 1:07 PMAstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcriptfool.com - April 25 at 1:07 PMAstraZeneca Gets a Boost From Sales of Its Cancer Drugsinvestopedia.com - April 25 at 12:40 PMAstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidancebenzinga.com - April 25 at 10:03 AMAstraZeneca rises as oncology business drives Q1 beatmsn.com - April 25 at 10:03 AMAstraZeneca shares jump on much stronger Q1 top and bottom lineza.investing.com - April 25 at 8:07 AMThe AstraZeneca share price lifts 5% on a top-and-bottom earnings beatmsn.com - April 25 at 8:07 AMAZN Stock Earnings: AstraZeneca Misses EPS, Beats Revenue for Q1 2024msn.com - April 25 at 8:07 AMAbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingprnewswire.com - April 25 at 8:00 AMAstraZeneca Earnings, Sales Rise, Beat Forecastsmsn.com - April 25 at 5:03 AMAstraZeneca beats revenue, profit estimates on resilient demandmsn.com - April 25 at 3:07 AMAstraZeneca beats top-line and bottom-line estimates; reaffirms FY24 outlookmsn.com - April 25 at 3:07 AMAstraZeneca beats first-quarter revenue, profit estimatesreuters.com - April 25 at 2:06 AMQ1 2024 resultsbusinesswire.com - April 25 at 2:00 AMMarks Group Wealth Management Inc Has $3.05 Million Position in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 24 at 9:27 AMAstraZeneca: What The Market's Missingseekingalpha.com - April 24 at 5:21 AMLiquid biopsy firm Angle signs new commercial agreement with AstraZenecamsn.com - April 24 at 4:00 AMAstraZeneca PLC AZNmorningstar.com - April 23 at 5:59 PM3 Underappreciated Pharmaceutical Stocks to Buy Before They Surgeinvestorplace.com - April 23 at 3:00 PMJennison Associates LLC Reduces Holdings in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 22 at 12:26 PMWith 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backingfinance.yahoo.com - April 22 at 9:43 AMabrdn plc Has $95.70 Million Stake in AstraZeneca PLC (NASDAQ:AZN)marketbeat.com - April 21 at 9:31 AM Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. AZN Media Mentions By Week AZN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.560.42▲Average Medical News Sentiment AZN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼2415▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Novartis News Abbott Laboratories News Pfizer News AbbVie News Sanofi News Merck & Co., Inc. News Vertex Pharmaceuticals News Bristol-Myers Squibb News Regeneron Pharmaceuticals News GSK News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityAutomatic Income (from home)Awesomely, LLCThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
